Private Equity Firms Buying Medical Practices Apr 2026

After a period of stabilization, healthcare private equity deal value reached an estimated , surpassing previous highs. This momentum has carried into 2026, driven by a massive "dry powder" stockpile and a pivot toward technology-enabled assets like AI-based telehealth and revenue cycle management.

: Firms centralize "back-office" functions (billing, HR, payroll), allowing doctors to focus theoretically on clinical care. private equity firms buying medical practices

: Declining reimbursements and the high cost of shifting to Value-Based Care (VBC) models make the financial backing of a large firm attractive. 3. The Impact: Cost, Quality, and Autonomy After a period of stabilization, healthcare private equity

This feature explores the evolving landscape of private equity (PE) acquisitions in the medical sector as of 2026. : Declining reimbursements and the high cost of

Physicians are increasingly seeking PE partnerships to navigate a complex modern landscape:

: While primary care was the early focus, firms are now aggressively targeting high-margin specialties including dermatology, ophthalmology, gastroenterology, and orthopedics.

: PE provides the funds needed to upgrade electronic medical record (EMR) systems and invest in advanced diagnostic tools.